Tuesday, November 11^th 2014

Consolidated Financial Results Nine Months of 2014

SIGNIFICANT TURNOVER GROWTH

GROSS PROFIT MARGIN IMPROVEMENT,

NET CASH POSITION, STRONG CASHFLOW GENERATION

CONSISTENTLY FOLLOWING ITS INVESTMENT PROGRAM

The upward trend observed in Sarantis Group turnover accelerated during the third quarter of 2014 having posted a 9.4% growth, thus leading to total Group sales growth of 6% in the nine months period, reaching €182.15 mil. compared to €171.83 million in the nine months of 2013.

The Group's significant turnover growth is a result of the GroupΆs strong market share in the market and continuous initiatives supporting its brands across the whole region of its operation.

The Group's foreign countries, being the largest contributor in terms of total sales amounting to 62% of the groupΆs turnover, continue to drive the GroupΆs growth having posted a 6.8% increase yoy, which corresponds to a 7.5% average growth in local currency.

Adding to the above is the remarkable growth of the Greek operation that is performing ahead of the market, exhibiting a 4.7% increase in the nine months of 2014 (12.9% growth in the third quarter of 2014).

Better sourcing and continuous projects aiming to lower production cost, continue to benefit the GroupΆs Gross Profit, resulting in further GroupΆs Gross Profit margin improvement to 49.73% during 9M 2014 from 49.48% during last yearΆs nine months.

According to the GroupΆs annual plan, the intensity of the marketing programs initiated in the beginning of the year in order to support the groupΆs top line growth started to slow down moving into the second half of the year, given that 70% of the annual budgeted marketing support was allocated in the first half of 2014.

This resulted in improved profitability margins in the nine month period of 2014 compared to previous quarters, while, according to the budget, further improvement is expected in the last quarter of 2014, which will lead to increased profitability margins year on year.

At the same time, the management is focused on operating leverage and controlling non-value added costs, which will lead to further improvement of operating margins and profitability.

Specifically:

• EBITDA settled at €15.37 mil. from €15.44 mil, with an EBITDA margin of 8.44% from 8.99% in 9M 2013 and 7.19% in the H1 2014.
• Earnings Before Interest and Tax (EBIT) reached €12.72 mil. from €12.66 mil. and EBIT margin settled at 6.98% from 7.37% in 9M 2013 and 5.75% in H1 2014.
• Earnings Before Tax (EBT) stood at €12.74 mil. from €13.63 mil. with the EBT margin reaching 6.99% from 7.93% in last yearΆs nine months and 5.91% in H1 2014.
• Net Profit* settled at €9.83 mil. from €10.81 mil. same period last year, while Net Profit margin reached 5.40% from 6.29% in 9M 2013 and 4.18% in H1 2014.
• Earnings Per Share (EPS) stood at €0.2826 from €0.3109 in 9M 2013.

 *It is noted that the Group's Net Profit is affected by an additional deferred tax of 0.75 mil. eur due to the recent acquisition of the Czech cosmetics trademarks company ASTRID TM.

On the balance sheet front, exhibiting its healthy financial position, Sarantis Group is able to invest behind initiatives to accelerate growth and return value to its shareholders.

As of the end of the nine month 2014 period, the Group maintains a net cash position of €6.7 mil., despite having paid an interim dividend for FY 2013 in January 2014 of approximately €9.7 mil. and following the acquisition of the Czech cosmetics trademarks company  ASTRID TM. of c. €6.5 mil.

Devoted on its investment program behind acquisitions, and, taking advantage of its strong balance sheet, the management has completed within October 2014 the acquisition of the NOXZEMA business in Greece from Procter & Gamble, at the agreed price of €8.7 mil. (Outflow within Q4 2014).

The Group's strategy is focused on product innovations within the Group's core business categories of mass market cosmetics and household products, the renewal and enrichment of the Group's brand portfolio, increasing its market shares, improving further productivity and production cost and continuing its investment plan behind value adding acquisitions that are able to provide high returns, enhance the Group's margins and offer synergies not only in terms of expenses and costs but also in the product innovation and product expansion front.

Looking into the future, we still have challenges ahead of us, however we expect to preserve the sales growth momentum and we believe that our initiatives behind organic and acquisitive growth together with plans to optimize further the production and control operational costs, will continue to produce strong cashflow and deliver the estimated FY 2014 financial results.